stockportfolio.pro
Amneal Pharmaceuticals, Inc. Gross Profit 2016–2025
Amneal Pharmaceuticals, Inc. (AMRX) annual gross profit by fiscal year, computed from SEC filings. Compound growth +7.2%/yr over 9 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $1.11B | 36.9% | +9.1% |
| FY 2024 | $1.02B | 36.5% | +24.4% |
| FY 2023 | $820.57M | 34.3% | +4.6% |
| FY 2022 | $784.71M | 35.5% | +2.0% |
| FY 2021 | $768.97M | 36.7% | +22.4% |
| FY 2020 | $628.39M | 31.5% | +78.0% |
| FY 2019 | $353.00M | 21.7% | -50.7% |
| FY 2018 | $716.40M | 43.1% | +36.2% |
| FY 2017 | $526.18M | 50.9% | -11.9% |
| FY 2016 | $597.46M | 58.7% | — |
Source: Amneal Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Amneal Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmneal Pharmaceuticals, Inc. — frequently asked questions
What is Amneal Pharmaceuticals, Inc.'s gross profit?
Amneal Pharmaceuticals, Inc. (AMRX) reported gross profit of $1.11B for fiscal year 2025, per its SEC filings.
How has Amneal Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2016 and 2025, AMRX's gross profit grew at roughly 7.2% per year (compound annual rate), from $597.46M to $1.11B.
Where does this data come from?
Figures are computed from Amneal Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.